Insulet Corp (PODD)
235.61
+4.08
(+1.76%)
USD |
NASDAQ |
Nov 01, 16:00
235.71
+0.10
(+0.04%)
After-Hours: 20:00
Insulet Revenue (Quarterly): 488.50M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 488.50M |
| March 31, 2024 | 441.70M |
| December 31, 2023 | 509.80M |
| September 30, 2023 | 432.70M |
| June 30, 2023 | 396.50M |
| March 31, 2023 | 358.10M |
| December 31, 2022 | 369.70M |
| September 30, 2022 | 340.80M |
| June 30, 2022 | 299.40M |
| March 31, 2022 | 295.40M |
| December 31, 2021 | 307.70M |
| September 30, 2021 | 275.60M |
| June 30, 2021 | 263.20M |
| March 31, 2021 | 252.30M |
| December 31, 2020 | 246.10M |
| September 30, 2020 | 234.00M |
| June 30, 2020 | 226.30M |
| March 31, 2020 | 198.00M |
| December 31, 2019 | 209.40M |
| September 30, 2019 | 192.10M |
| June 30, 2019 | 177.10M |
| March 31, 2019 | 159.60M |
| December 31, 2018 | 164.88M |
| September 30, 2018 | 151.08M |
| June 30, 2018 | 124.26M |
| Date | Value |
|---|---|
| March 31, 2018 | 123.58M |
| December 31, 2017 | 130.56M |
| September 30, 2017 | 121.78M |
| June 30, 2017 | 109.76M |
| March 31, 2017 | 101.71M |
| December 31, 2016 | 103.58M |
| September 30, 2016 | 94.87M |
| June 30, 2016 | 87.33M |
| March 31, 2016 | 81.21M |
| December 31, 2015 | 83.80M |
| September 30, 2015 | 71.39M |
| June 30, 2015 | 60.55M |
| March 31, 2015 | 48.15M |
| December 31, 2014 | 15.16M |
| September 30, 2014 | 74.98M |
| June 30, 2014 | 72.01M |
| March 31, 2014 | 69.16M |
| December 31, 2013 | 68.53M |
| September 30, 2013 | 61.10M |
| June 30, 2013 | 60.09M |
| March 31, 2013 | 57.36M |
| December 31, 2012 | 57.83M |
| September 30, 2012 | 54.75M |
| June 30, 2012 | 51.04M |
| March 31, 2012 | 47.75M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
198.00M
Minimum
Mar 2020
509.80M
Maximum
Dec 2023
323.43M
Average
299.40M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| Baxter International Inc | 3.812B |
| Boston Scientific Corp | 4.209B |
| Abbott Laboratories | 10.64B |
| Globus Medical Inc | 629.69M |
| Bioventus Inc | 151.22M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 188.60M |
| Total Expenses (Quarterly) | 433.90M |
| EPS Diluted (Quarterly) | 2.59 |
| Enterprise Value | 17.10B |
| Gross Profit Margin (Quarterly) | 67.74% |
| Profit Margin (Quarterly) | 38.61% |
| Earnings Yield | 2.33% |
| Operating Earnings Yield | 1.52% |
| Normalized Earnings Yield | 2.334 |